
Upadacitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. It is prescribed for selected inflammatory conditions affecting the joints, skin or bowel when other treatments are unsuitable or have not provided adequate control.
| Generic Name | Upadacitinib |
| Strength | 30 mg |
| Manufacturer | MSN Laboratories Private Limited |
| Packing | 30 Tablets |
| Prescribed For | Suppresses an overactive immune system to treat chronic inflammatory and autoimmune conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Tablets | $130 | £97 | A$182 | NZ$227 | ₱8,139 | ₩175,435 | lei 592 | HK$1,019 | RM529 | ฿4,247 | د.إ477 |
Upadacitinib blocks enzymes called Janus kinases, or JAKs, which transmit inflammatory signals within the immune system. By interrupting these signals, it reduces excessive immune activity, inflammation and tissue damage. This can help relieve joint, skin and bowel symptoms.
Upadacitinib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.